Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE‐IT by Brian Olshansky, Deepak L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Peter R. Kowey, James A. Reiffel, Jean‐Claude Tardif, Christie M. Ballantyne, Mina K. Chung

Get full text

Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI by Benjamin E. Peterson, Deepak L. Bhatt, Ph. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Rebecca A. Juliano, Lixia Jiao, Ralph T. Doyle, Craig Granowitz, C. Michael Gibson, Duane Pinto, Robert P. Giugliano, Matthew J. Budoff, Jean‐Claude Tardif, Subodh Verma, Christie M. Ballantyne

Get full text

Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC by Benjamin E. Peterson, M.D, Deepak L. Bhatt, M.D., M.P.H, Ph.Gabriel Steg, M.D, Michael Miller, M.D, Eliot A. Brinton, M.D, Terry A. Jacobson, M.D, Steven B. Ketchum, Rebecca A. Juliano, Ph.D., Lixia Jiao, Ph.D, Ralph T. Doyle, Jr., B.A, Craig Granowitz, M.D., Ph.D, C. Michael Gibson, M.S., M.D, Duane Pinto, M.D, Robert P. Giugliano, M.D., S.M, Matthew J. Budoff, M.D, Jean-Claude Tardif, M.D, Subodh Verma, M.D., Ph.D, Christie M. Ballantyne, M.D

Get full text